Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos

Br J Cancer 2000 Jul;83(1):104-11
Magnani C, Agudo A, Gonzalez CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar A, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B
Cancer Epidemiology Unit, S Giovanni B Hospital and Regional Centre for Cancer Epidemiology and Prevention, Torino, Italy.

Insufficient evidence exists on the risk factors of pleural mesothelioma from non-occupational exposure to asbestos. A population-based case-control study was carried out in six areas from Italy, Spain and Switzerland. Information was collected for 215 new histologically confirmed malignant mesothelioma cases and 448 controls. A panel of industrial hygienists assessed asbestos exposure separately for occupational, domestic and environmental sources. Classification of domestic and environmental exposure was based on a complete residential history, presence and use of asbestos at home, asbestos industrial activities in the surrounding area, and their distance from the dwelling. In 53 cases and 232 controls without evidence of occupational exposure to asbestos, moderate or high probability of domestic exposure was associated with an increased risk adjusted by age and sex: odds ratio (OR) 4.81, 95% confidence interval (CI) 1.8-13.1. This corresponds to three situations: cleaning asbestos-contaminated clothes, handling asbestos material and presence of asbestos material susceptible to damage. The estimated OR for high probability of environmental exposure (living within 2000 m of asbestos mines, asbestos cement plants, asbestos textiles, shipyards, or brakes factories) was 11.5 (95% CI 3.5-38.2). Living between 2000 and 5000 m from asbestos industries or within 500 m of industries using asbestos could also be associated with an increased risk. A dose-response pattern appeared with intensity of both sources of exposure. It is suggested that low-dose exposure to asbestos at home or in the general environment carries a measurable risk of malignant pleural mesothelioma.

Source

PMID: 10883677, UI: 20338736
Click here to order or save article

If you have any questions regarding treatment options or your legal rights, please contact us.

Free Mesothelioma Information Packet

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

Yes   No

Mesothelioma Mesothelioma Treatment
Conventional Therapies Alternative Treatments Experimental Therapies Treatment by Stage Mesothelioma Doctors Mesothelioma Experts Clinical Trials Mesothelioma Clinics Ask Your Doctor Caregivers and the Aging Mesothelioma Research Review Studies Case Studies Etiological Studies Diagnostic Studies Therapy Studies Mesothelioma Resources Counseling Resources Mesothelioma Treatment Alerts
Asbestos Cancer Asbestos Exposure Mesothelioma News Veterans & Mesothelioma Mesothelioma Attorney FREE Case Evaluation Top Mesothelioma Doctors

Raphael Bueno, M.D.
Dr. Raphael Bueno is the Associate Chief of Medicine in the Division of Thoracic Surgery at Boston's Brigham and Women's Hospital specializing in the treatment of malignant mesothelioma.

Hedy Lee Kindler, M.D.
Dr. Hedy Lee Kindler is a top cancer researcher investigating new treatments for malignant mesothelioma and is an Associate Professor of Medicine at the University of Chicago Medical Center in the Department of Hematology/Oncology.

David Rice, M.D.
Dr. David Rice is an Associate Professor and Assistant Surgeon at The University of Texas M.D. Anderson Cancer Center where he serves as the director of the Minimally Invasive Surgery and Mesothelioma programs.

This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
verify here.